食管旁疝修补联合Roux-en-Y胃旁路术可减少BMI≥35患者短期疝复发并带来代谢获益:15年经验
回顾性队列研究纳入BMI≥35的大型食管旁疝患者397例,倾向匹配后各组90例,比较腹腔镜食管旁疝修补联合Roux-en-Y胃旁路术(LPEHr/LRYGB)与单纯修补(LPEHr)。联合组前36个月疝复发率显著降低(p=0.015),但72个月时差异无统计学意义(p=0.6);联合组BMI降低更显著(-10.2 vs -2.2 kg/m2,p<0.001)。
要点
- BMI≥35的食管旁疝患者,联合RYGB可降低术后36个月内疝复发率。
- 联合RYGB带来显著额外代谢获益,随访BMI降低10.2 kg/m2。
- 长期(72个月)疝复发率两组无差异,再手术时间无差异。
核心结论
- BMI≥35患者行LPEHr/LRYGB较单纯LPEHr显著降低前36个月食管旁疝复发率,并带来显著BMI降低的代谢获益,但72个月及以后复发率无差异。
研究设计与样本
- 单中心前瞻性维护数据库的回顾性 review,纳入2009年1月1日至2024年1月1日期间BMI≥35、II–IV型大型食管旁疝(胸腔内胃≥35%)患者。
- 共397例接受初次LPEHr/LRYGB(n=223)或LPEHr(n=174),倾向匹配后每组90例,中位随访联合组57个月、单纯组53个月。
- 排除既往上消化道手术或除LRYGB外的同期减重手术者,采用Kaplan-Meier和Log-rank检验比较倾向匹配组。
主要发现
- 倾向匹配后,LPEHr/LRYGB组前36个月食管旁疝复发率显著低于LPEHr组(p=0.015),但随后复发率趋同,72个月随访时差异无统计学意义(p=0.6)。
- 两组再手术时间无显著差异(p=0.447)。
- 随访时LPEHr/LRYGB组BMI降低显著大于LPEHr组(-10.2 kg/m2 vs -2.2 kg/m2,p<0.001)。
- 疝复发时质子泵抑制剂(PPI)使用率两组无显著差异(p=0.065)。
- LPEHr组补片使用率显著高于联合组(59% vs 7%,p<0.001),但补片使用与降低疝复发无关(p=0.273)。
临床怎么用
- 对BMI≥35的大型食管旁疝患者,可考虑LPEHr/LRYGB以降低短期复发并获得代谢获益。
- 需告知患者联合手术的短期复发优势在72个月后不再显著,长期复发风险仍存在。
局限性
- 单中心回顾性研究,样本量有限,倾向匹配后每组90例。
- 随访时间不等,长期结果可能受失访影响。
- 补片使用在两组间不均衡,可能影响复发率比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Obesity is a risk factor for paraesophageal hernias (PEH), with reported higher prevalence in patients with obesity. Similarly, higher body mass index (BMI) levels adversely affect PEH repair outcomes, with well-documented hernia recurrence rates in patients with obesity. We sought to investigate PEH recurrence in combined laparoscopic PEH repair with laparoscopic Roux-en-Y gastric bypass (LPEHr/LRYGB) vs laparoscopic PEH repair alone (LPEHr) in patients with obesity. We hypothesized that LPEHr/LRYGB is associated with reduced PEH recurrence and improved metabolic outcomes compared to LPEHr. METHODS: A retrospective review of a prospectively maintained database from a single academic institution was conducted. We included patients with BMI ≥ 35, with type II, III, and IV large PEH (defined as ≥ 35% of intrathoracic stomach) operated from 1/1/2009 to 1/1/2024. Patients with previous foregut surgery or concomitant weight loss surgery other than LRYGB were excluded. The primary outcome was overall PEH recurrence. Secondary outcomes were defined by metabolic benefit, measured by reduction in BMI between the two groups, and acid reflux symptoms at time of recurrence, measured by proton pump inhibitor (PPI) use. Additionally, we looked at procedural variability in the surgeries. Statistical analysis was performed by comparing propensity-matched groups using Kaplan-Meier estimates and a Log-rank test. RESULTS: A total of 397 patients underwent index LPEHr/LRYGB (n = 223) or LPEHr (n = 174). After propensity matching, there were a total of 180 patients with 90 patients in each group. Median follow-up after propensity matching for LPEHr/LRYGB was 57 months vs 53 months for LPEHr. There was a significant reduction of PEH recurrence rate for the first 36 months of follow-up in patients who underwent LPEHr/LRYGB compared to LPEHr (p = 0.015); however, the recurrence rates converged subsequently and at 72 months of follow-up, the difference was no longer significant (p = 0.6). Time until reoperation between the groups was not significantly different (p = 0.447). Patients who underwent LPEHr/LRYGB had a significant reduction in BMI compared to LPEHr at follow-up (- 10.2 kg/m2 vs - 2.2 kg/m2; p < 0.001). Use of PPI at time of PEH recurrence was not significantly different between the groups (p = 0.065). While use of mesh was significantly higher in the LPEHr group (59% vs 7%; p < 0.001), use of mesh was not associated with lower PEH recurrence (p = 0.273). CONCLUSION: Patients with obesity with a BMI ≥ 35 who underwent LPEHr/LRYGB had a significant reduction in early PEH recurrence rate for the first 36 months compared to LPEHr, in addition to significant added metabolic benefit measured by long-term reduction in BMI. The long-term PEH recurrence rate between these groups showed no difference at 72 months of follow-up and beyond.
引用
- Rahimi-Ardabily A, Kapran M, Chang A, et al. Paraesophageal hernia repair combined with Roux-en-Y gastric bypass reduces short-term hernia recurrence with added metabolic benefit in patients with BMI ≥ 35: A 15-year experience. Surg Endosc. 2025. PMID: 40571796. doi:10.1007/s00464-025-11950-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。